DK3390412T3 - Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser - Google Patents

Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser Download PDF

Info

Publication number
DK3390412T3
DK3390412T3 DK16809425.8T DK16809425T DK3390412T3 DK 3390412 T3 DK3390412 T3 DK 3390412T3 DK 16809425 T DK16809425 T DK 16809425T DK 3390412 T3 DK3390412 T3 DK 3390412T3
Authority
DK
Denmark
Prior art keywords
diphenyl
water
soluble derivatives
diazole compounds
diazole
Prior art date
Application number
DK16809425.8T
Other languages
Danish (da)
English (en)
Inventor
Christian Griesinger
Sergey Ryazanov
Armin Giese
Felix Schmidt
Andrei Leonov
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK3390412T3 publication Critical patent/DK3390412T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/11Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16809425.8T 2015-12-14 2016-12-14 Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser DK3390412T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15199972 2015-12-14
PCT/EP2016/081084 WO2017102893A1 (en) 2015-12-14 2016-12-14 Water-soluble derivatives of 3,5-diphenyl-diazole compounds

Publications (1)

Publication Number Publication Date
DK3390412T3 true DK3390412T3 (da) 2021-06-21

Family

ID=54850017

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16809425.8T DK3390412T3 (da) 2015-12-14 2016-12-14 Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser

Country Status (21)

Country Link
US (1) US10308671B2 (enExample)
EP (1) EP3390412B1 (enExample)
JP (1) JP6898931B2 (enExample)
KR (1) KR102671166B1 (enExample)
CN (1) CN108473516B (enExample)
AU (1) AU2016372408B2 (enExample)
BR (1) BR112018011994B1 (enExample)
CA (1) CA3008334C (enExample)
CL (1) CL2018001570A1 (enExample)
DK (1) DK3390412T3 (enExample)
ES (1) ES2873510T3 (enExample)
HU (1) HUE054815T2 (enExample)
IL (1) IL260011B (enExample)
MX (1) MX379522B (enExample)
NZ (1) NZ742979A (enExample)
PH (1) PH12018501276A1 (enExample)
PL (1) PL3390412T3 (enExample)
PT (1) PT3390412T (enExample)
RU (1) RU2764131C2 (enExample)
WO (1) WO2017102893A1 (enExample)
ZA (1) ZA201803865B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH713150A2 (fr) * 2016-11-23 2018-05-31 Eta Sa Mft Horlogere Suisse Mécanisme régulateur à résonateur rotatif à guidage flexible entretenu par un échappement libre à ancre.
US10368502B2 (en) 2017-09-25 2019-08-06 Multiple Energy Technologies Llc Bioceramic and carbon-based hydroponic systems, methods and devices
EP4368184A3 (en) 2019-11-19 2024-07-31 Modag GmbH Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein
US20250161273A1 (en) * 2022-03-01 2025-05-22 Modag Gmbh Pharmaceutical composition comprising diphenyldiazole derivatives and methods of use
CN115337301A (zh) * 2022-07-22 2022-11-15 汕头大学医学院第一附属医院 Anle138b在制备改善饮食诱导胰岛素抵抗药物中的应用
CN116399983B (zh) * 2023-06-09 2023-08-15 天津辰欣药物研究有限公司 一种利用gc-ms法检测二叔丁基氯甲基磷酸酯残留量的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745625B2 (en) * 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
NZ564326A (en) * 2005-06-16 2010-01-29 Cv Therapeutics Inc Prodrugs of A2B adenosine receptor antagonists
EP2272822A4 (en) * 2008-03-31 2012-01-18 Renascience Co Ltd PLASMINOG ACTIVATOR-1 HEMMER
EP2687513B1 (en) * 2008-06-09 2020-12-02 Ludwig-Maximilians-Universität München Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
JP6069661B2 (ja) * 2010-06-24 2017-02-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 種々のアミロイドβペプチドアロフォームレベルの調節における組成物及びその使用
SMT201700306T1 (it) * 2012-06-08 2017-07-18 Theravance Biopharma R&D Ip Llc Inibitori di neprilisina

Also Published As

Publication number Publication date
CN108473516B (zh) 2021-06-18
RU2018125590A (ru) 2020-01-20
CA3008334C (en) 2024-01-02
ZA201803865B (en) 2019-04-24
RU2764131C2 (ru) 2022-01-13
KR20180089511A (ko) 2018-08-08
PL3390412T3 (pl) 2021-10-25
CA3008334A1 (en) 2017-06-22
PH12018501276A1 (en) 2019-01-28
ES2873510T3 (es) 2021-11-03
IL260011B (en) 2021-12-01
PT3390412T (pt) 2021-06-22
US20180370997A1 (en) 2018-12-27
MX2018006877A (es) 2018-09-18
IL260011A (en) 2018-07-31
CL2018001570A1 (es) 2018-12-28
JP2019501167A (ja) 2019-01-17
EP3390412B1 (en) 2021-04-14
MX379522B (es) 2025-03-10
WO2017102893A1 (en) 2017-06-22
KR102671166B1 (ko) 2024-05-31
CN108473516A (zh) 2018-08-31
RU2018125590A3 (enExample) 2020-04-21
AU2016372408A1 (en) 2018-06-21
NZ742979A (en) 2022-05-27
US10308671B2 (en) 2019-06-04
JP6898931B2 (ja) 2021-07-07
BR112018011994A2 (pt) 2018-12-04
BR112018011994B1 (pt) 2022-07-19
EP3390412A1 (en) 2018-10-24
HUE054815T2 (hu) 2021-10-28
AU2016372408B2 (en) 2021-05-13

Similar Documents

Publication Publication Date Title
IL286839A (en) Propyne-indole compounds
DK3319956T3 (da) Substituerede oxopyridinderivater
LT3377488T (lt) Heterocikliniai junginiai, kaip imunomoduliatoriai
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
IL262335A (en) Stable nimopidine parenteral formulation
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
LT3402792T (lt) Chinolin-2-ono dariniai
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
LT3457851T (lt) Sobetiromo dariniai
EP3283171A4 (en) DERIVATIVES OF AMPHOTERICIN B
LT3371168T (lt) Indolin-2-ono dariniai
SMT202200173T1 (it) Composti
EP3541200C0 (en) POWDERED FORMULATIONS
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3418273T3 (da) Derivater af flavagliner
DK3390412T3 (da) Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser
EP3333163A4 (en) SUBSTITUTED GUANIDINE DERIVATIVE
LT3347360T (lt) Junginiai, naudingi ror-gama-t slopinimui
BR112018001062A2 (pt) compostos inovadores
LT3253749T (lt) Junginiai, pasižymintys priešnavikiniu aktyvumu
HUE056928T2 (hu) Új vegyületek
DK3672941T3 (da) Pyridylpyridonforbindelser
DK3645513T3 (da) Benzazepinderivater
EP3440070C0 (en) 8-HYDROXY-QUINOLINE DERIVATIVES REVERSING MULTIDRUG RESISTANCE